Joanne Ino Hsu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anti-Allergic Agents | 1 | 2022 | 150 | 0.750 |
Why?
|
Urticaria | 1 | 2022 | 150 | 0.750 |
Why?
|
Clone Cells | 1 | 2018 | 1659 | 0.490 |
Why?
|
Eye Diseases | 1 | 2019 | 654 | 0.450 |
Why?
|
Cisplatin | 1 | 2018 | 1650 | 0.410 |
Why?
|
Dermatitis, Atopic | 1 | 2019 | 721 | 0.400 |
Why?
|
Doxorubicin | 1 | 2018 | 2224 | 0.390 |
Why?
|
Hematopoiesis | 1 | 2018 | 2049 | 0.320 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3613 | 0.210 |
Why?
|
Pancytopenia | 1 | 2023 | 102 | 0.200 |
Why?
|
Bone Marrow Diseases | 1 | 2023 | 233 | 0.190 |
Why?
|
Cyclosporine | 1 | 2022 | 778 | 0.170 |
Why?
|
Hematologic Diseases | 1 | 2023 | 496 | 0.160 |
Why?
|
Mutation | 4 | 2024 | 30045 | 0.140 |
Why?
|
Thalidomide | 1 | 2022 | 885 | 0.140 |
Why?
|
Phosphoproteins | 2 | 2016 | 2448 | 0.130 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 718 | 0.130 |
Why?
|
Acne Vulgaris | 1 | 2021 | 358 | 0.130 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13637 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1051 | 0.120 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1827 | 0.120 |
Why?
|
Fungi | 1 | 2016 | 338 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2018 | 1230 | 0.110 |
Why?
|
Fungal Proteins | 1 | 2016 | 910 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 3 | 2022 | 3396 | 0.100 |
Why?
|
Dermatology | 1 | 2021 | 918 | 0.090 |
Why?
|
Chromatin | 1 | 2022 | 2960 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1896 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2018 | 4278 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1974 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1887 | 0.070 |
Why?
|
Chronic Disease | 1 | 2022 | 9320 | 0.070 |
Why?
|
Proteome | 2 | 2016 | 1862 | 0.070 |
Why?
|
Multiple Myeloma | 1 | 2022 | 5146 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2018 | 10441 | 0.050 |
Why?
|
Genes, myc | 1 | 2022 | 390 | 0.050 |
Why?
|
DNA Repair | 2 | 2022 | 2045 | 0.040 |
Why?
|
Genes, p53 | 1 | 2022 | 712 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22163 | 0.040 |
Why?
|
Humans | 10 | 2024 | 761423 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2021 | 825 | 0.040 |
Why?
|
Syndrome | 1 | 2023 | 3268 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2022 | 1320 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2141 | 0.030 |
Why?
|
Leukemia | 1 | 2024 | 1522 | 0.030 |
Why?
|
Genome, Fungal | 1 | 2016 | 203 | 0.030 |
Why?
|
Mice | 2 | 2018 | 81509 | 0.030 |
Why?
|
Solid Phase Extraction | 1 | 2014 | 28 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2021 | 1048 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2024 | 3110 | 0.030 |
Why?
|
Phenotype | 2 | 2023 | 16606 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2916 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2014 | 983 | 0.020 |
Why?
|
Animals | 2 | 2018 | 168441 | 0.020 |
Why?
|
Gene Deletion | 1 | 2016 | 2667 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2811 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16979 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1188 | 0.020 |
Why?
|
Aged | 1 | 2018 | 169235 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8320 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13449 | 0.010 |
Why?
|
Middle Aged | 1 | 2018 | 220826 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12125 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7409 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5820 | 0.010 |
Why?
|
Male | 1 | 2018 | 360736 | 0.010 |
Why?
|
Female | 1 | 2018 | 392581 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23441 | 0.010 |
Why?
|